OPTIMAL CHOICE OF STONE DISEASE’ SURGICAL TREATMENT IN PATIENTS SUFFERED PROSTATE CANCER: RETROSPECTIVE ANALYSIS
https://doi.org/10.38181/2223-2427-2020-4-11-17
Abstract
There are patients suffered prostate cancer and diagnosed with stone disease in urological centres. These cases represent non-standard issue of choosing the optimal surgical treatment. Currently clinical recommendations haven’t described the particular answer for this answer yet. There is also lack of information published in literature foсused on the issue.
Aim of the study was to determine the optimal choice of surgical treatment for patients diagnosed with stone disease and prostate cancer.
Materials and methods: Retrospective study of patients diagnosed with prostate cancer and stone disease for the period from 2006 to 2019 was performed. Among 2047 in-patient cases of prostate cancer 71 patients with stone disease were included.
Results: 49 of 71 (69%) patients diagnosed with stone disease had indications for surgical treatment at the moment of hospitalisation. Stages of prostate cancer in this group were T1-T2 (91,7%) and T3(8,3%). 25 patients (51%) had kidney stone disease, 23 patients (47%) – ureter stone disease and only 1 patient – kidney and ureter stone disease. 37 patients (75%) presented complains related to stone disease, other cases (25%) were asymptomatic. Surgical treatment of stone disease primarily was performed in the majority of cases (72,2%). Surgical treatment of prostate cancer subsequently included radical prostatectomy in most cases 7 (86,1%). Simultaneous surgical treatment of both diseases haven’t performed in this study.
Conclusion: The main factors influencing the decision making of optimal surgical treatment for this group of patients were clinical presentation and group of prostate cancer risk.
About the Authors
N. I. SorokinRussian Federation
Sorokin Nikolai Ivanovich – Dr. Sc., professor, Department of Urology and Andrology, Faculty of Fundamental Medicine, urologist, oncologist, researcher of Department of urology, Medical Scientific and Educational Center
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
A. M. Pshikhachev
Russian Federation
Pshikhachev Akhmed Mukhamedovich – Dr. Sc., urologist, oncologist, Department of urology, Medical Scientific and Educational Center
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
M. B. Zhumataev
Russian Federation
Zhumataev Marat Bugumbaevich – urologist, PhD student, Department of urology and andrology, Faculty of Fundamental Medicine
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
K. V. Mikheev
Russian Federation
Mikheev Konstantin Vitalevich – resident at the Department of Urology and Andrology, Faculty of Fundamental Medicine
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
G. N. Akopyan
Russian Federation
Akopyan Gagik Nersesovich – Dr. Sc., professor, Research
Bol'shaya Pirogovskaya st., 2 bld. 1, Moscow, 119435
E. V. Shpot
Russian Federation
Shpot Evgeny Valerievich – Dr. Sc., professor, Head of department of oncourology
Bol'shaya Pirogovskaya st., 2 bld. 1, Moscow, 119435
A. V. Kadrev
Russian Federation
Kadrev Aleksey Viktorovich – PhD, Head of Ultrasound Diagnostics Department; Researcher, Department of Urologand Andrology, Medical Research and Educational Center
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
V. K. Dzitiev
Russian Federation
Dzitiev Vitalii Kazikhanovich – PhD, Head of the urologic department, Medical Scientific and Educational Center
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
D. M. Kamalov
Russian Federation
Kamalov David Mikhailovich – PhD, urologist, Medical Scientific and Educational Center, senior lecturer at the Department of Urology and Andrology, Faculty of Fundamental Medicine
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
M. E. Chalyy
Russian Federation
Chalyy Mikhail Evgenievich – Dr. Sc., professor, Department of urology and andrology, Faculty of Fundamental Medicine, researcher of Department of Urology, Medical Scientific and Educational Center
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
A. A. Kamalov
Russian Federation
Kamalov Armais Albertovich – academician of Russian Academy of Sciences, Dr. Sc., head of Department of urology and andrology, Faculty of Fundamental Medicine, Director Medical Scientific and Educational Center
Lomonosovskiy prospect, 27 bld. 10, Moscow, 119192
References
1. Trinchieri A. Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab, 2008. 5(2): pp. 101-6.
2. Scales C., Smith A., Hanley J., Saigal C. Prevalence of kidney stones in the United States. Eur Urol, 2012. 62(1), pp. 160-5.
3. Coe F., Evan A., Worcester E. Kidney stone disease. J Clin Invest, 2005. 115(10), p. 2598-608.
4. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015. 136(5), pp. E359-86.
5. Ilić M., Vlajinac H., Marinković J. Case-control study of risk factors for prostate cancer. Br J Cancer, 1996. 74(10), p. 1682-6.
6. Alyaev Yu.G., Rudenko V.I., Askarov M.S. Treatment of patients with urolithiasis in combination with benign prostatic hyperplasia. Surgery. Magazine them. N.I. Pirogov. 2008. No. 3, pp. 53-57]. [In Russ].
7. Glybochko P.V., Alyaev Yu.G., Pshikhachev A.M., Sorokin N.I., Dymov A.M. Determination of treatment tactics for patients with bladder cancer in combination with prostatic hyperplasia. Urology. 2016. No5, pp. 92-96]. (In Russ).
Review
For citations:
Sorokin N.I., Pshikhachev A.M., Zhumataev M.B., Mikheev K.V., Akopyan G.N., Shpot E.V., Kadrev A.V., Dzitiev V.K., Kamalov D.M., Chalyy M.E., Kamalov A.A. OPTIMAL CHOICE OF STONE DISEASE’ SURGICAL TREATMENT IN PATIENTS SUFFERED PROSTATE CANCER: RETROSPECTIVE ANALYSIS. Surgical practice (Russia). 2020;(4):11-17. (In Russ.) https://doi.org/10.38181/2223-2427-2020-4-11-17